- Learning about medical tests
- Bilirubin
- Blood count
- Blood gases
- Bone marrow
- Brain scan
- Bronchoscopy
- CD4 cell count
- Computed tomography (CT) scan
- Creatinine clearance
- Dual-energy X-ray absorptiometry (DEXA) scan
- Endoscopy
- Genotypic resistance tests
- Karnofsky score
- Lactate
- Lipid test
- Liver function
- Lumbar puncture
- Lung function tests
- Magnetic resonance imaging (MRI)
- Nerve conduction tests
- Neuro-cognitive tests
- Papanicolaou (Pap) smear
- Phenotypic resistance tests
- Purified protein derivative (PPD) skin tests
- Serology
- Sigmoidoscopy and rectal biopsy
- Specimen culture
- Sputum tests
- Viral load
- X-ray & ultrasound
Computed tomography (CT) scan
When and why
(CT) is a widely used imaging technology which assists in the diagnosis and treatment of many conditions. It is also known as computerised axial tomography (CAT) and computerised transaxial tomography (CTAT).
In the context of HIV, it can be helpful in the diagnosis of cancers and infections in the head, chest, gut and lymph nodes, and is especially useful for visualising space-occupying lesions. A CT scan may be conducted to assess lipodystrophy, although the DEXA scan is generally favoured in this regard.
The technology assesses the tissue density of narrow slices (1-10 mm) of your body, spaced at intervals of 5-10 mm. From these slices, a full CT image is generated which can show subtle changes in tissue type, lesions, and evidence of infections.
During the scan, you lie on a table while the scanner passes over your body. You do not feel anything while undergoing a CT scan.
How it will help
Accurate diagnosis of opportunistic infections and malignancies will facilitate appropriate treatment.
latest aidsmap news
- Updated British HIV pregnancy guidelines published
- Incidence increasing of HIV-associated multicentric Castleman's disease, a relatively rare lymphatic cancer
- Rapid progression of liver fibrosis in HIV-positive gay men recently infected with hepatitis C
- Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
- Long-term HIV treatment cuts risk of hardening of coronary artery
- Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks
- Will male circumcision protect women, ask advocates?
- Do not use HIV tests bought over the internet, warns UK medicines regulators
- `Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes
- Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
